Rankings
▼
Calendar
ANIK Q1 2021 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
Q1 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$34M
-3.1% YoY
Gross Profit
$21M
61.2% margin
Operating Income
$1M
3.7% margin
Net Income
$3M
8.3% margin
EPS (Diluted)
$0.20
QoQ Revenue Growth
+4.9%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$362M
Total Liabilities
$86M
Stockholders' Equity
$277M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$35M
-3.1%
Gross Profit
$21M
$21M
-1.1%
Operating Income
$1M
$7M
-82.3%
Net Income
$3M
$6M
-51.0%
Revenue Segments
Product
$34M
50%
Joint Pain Management Therapies
$19M
28%
Joint Preservation and Restoration
$12M
18%
Manufactured Product, Other
$3M
4%
Geographic Segments
UNITED STATES
$25M
82%
Europe
$5M
18%
← FY 2021
All Quarters
Q2 2021 →